Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-21-001809

Options or other derivatives

  • SVP, Chief Technical Officer acquired 36,855 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LaBarre Michael J. · SVP, Chief Technical Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-15 Grant or award : show line 1 in the form Option to Purchase Common Stock +23,311 $49.84 2031-02-15 23,311 23,311 D
2021-02-15 Grant or award : show line 2 in the form Restricted Stock Units +13,544 $0.00 13,544 13,544 D
Loading xslF345X03/edgar.xml…